- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06096454
Effect of Life Style Modification and Metformin on Hypothyroidism With Insulin Resistance
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Hypothyroidism happens when the thyroid does not create and release enough thyroid hormone in the body this make the metabolism slow down .
Thyroid hormones T3 and T4 maintain a fine balance of glucose homeostasis by acting as insulin agonistic and antagonistic. Hypothyroidism can break this equilibrium and alter glucose metabolism, which can lead to insulin resistance.
Insulin resistance is defined clinically as the inability of a known quantity of exogenous or endogenous insulin to increase glucose uptake and utilization in an individual as much as it does in a normal population.
In this work we assess the lifestyle modification (i.e. diet and exercise)and metformin on insulin resistance
Study Type
Enrollment (Estimated)
Phase
- Phase 4
Contacts and Locations
Study Contact
- Name: hossam mohamed youssef, MBBCh
- Phone Number: 01014647504
- Email: dr.hossam.youssef96@gmail.com
Study Contact Backup
- Name: Mohammad HM AbdEllah-Alawi, MD
- Phone Number: +201115353591
- Email: mhmdifferent@aun.edu.eg
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
1_ above 18 years with insulin resistance criteria according (The American Association of Clinical Endocrinologists (AACE)
- 1)BMI of 25 kg/m2 or higher
- 2)Waist circumference of more than 102 cm in men or more than 88 cm in women
- 3)Triglyceride level of 150 mg/dl . or higher.
- 4) HDL-C level of less than 40 mg/dl in men or less than 50 mg/dl in women
- 5)Blood pressure of 130 /85 mmhg or higher
- 6)Fasting glucose level of 110 ـ126 mg /dl
7)Glucose level of more than 140 mg/dl2 hour after administration of 75 g of glucose
2_ Patients known to have hypothyroidism and achieving diagnostic criteria of insulin resistance
Exclusion Criteria:
- Patients don't have other secondary causes of insulin resistance i.e. acromegaly, Cushing syndrome 3- patient have renal or hepatic impairment (contraindication to metformin )
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: metformin ,life style
known to have hypothyroidism with insulin resistance received metformin (1000mg,once daily per oral ) and applied life style modification
|
effect of life style modification and metformin on hypothyroidism with insulin resistance
Other Names:
|
No Intervention: placebo
known to have hypothyroidism with insulin resistance not received metformin and not applied life style modification
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change of waist circumference
Time Frame: 6 months
|
change of waist circumference from baseline and at the end of study
|
6 months
|
Dose of levothyroxine
Time Frame: 6 months
|
change of the dose of levothyroxine
|
6 months
|
change of parameter of metabolic syndrome
Time Frame: 6 months
|
change of score of parameter of metabolic syndrome
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mohammad HM AbdEllah-Alawi, MD, Assiut University
Publications and helpful links
General Publications
- Roberts CK, Hevener AL, Barnard RJ. Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr Physiol. 2013 Jan;3(1):1-58. doi: 10.1002/cphy.c110062.
- Crandall JP, Knowler WC, Kahn SE, Marrero D, Florez JC, Bray GA, Haffner SM, Hoskin M, Nathan DM; Diabetes Prevention Program Research Group. The prevention of type 2 diabetes. Nat Clin Pract Endocrinol Metab. 2008 Jul;4(7):382-93. doi: 10.1038/ncpendmet0843. Epub 2008 May 20.
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- life style in hypothyroidism
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypothyroidism
-
Kerman University of Medical SciencesCompletedPrediction Hypothyroidism Patients Using Machine Learning Algorithms | Identification of Important Symptoms of HypothyroidismIran, Islamic Republic of
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...RecruitingHypothyroidism; IrradiationItaly
-
Cooperativas Lacteas UnidasGalician South Health Research InstituteNot yet recruitingSubclinical HypothyroidismSpain
-
IBSA Institut Biochimique SACompletedHypothyroidism;PostablativeUnited States
-
Peking Union Medical College HospitalBeijing Municipal Science & Technology CommissionCompletedSubclinical HypothyroidismChina
-
University Hospital DubravaRecruitingHypothyroidism PrimaryCroatia
-
VA Office of Research and DevelopmentCentral Arkansas Veterans Healthcare SystemCompletedSubclinical HypothyroidismUnited States
-
University of Colorado, DenverCharite University, Berlin, GermanyTerminatedHypothyroidism | Postsurgical HypothyroidismUnited States
-
AbbottDimension ResearchCompletedSubclinical HypothyroidismPakistan
Clinical Trials on Metformin
-
Anji PharmaSuspendedDiabetes Mellitus, Type 2Spain, United States, Canada, Hungary, Brazil, Czechia, Poland, Bulgaria
-
ShionogiCompleted
-
NuSirt BiopharmaCompletedType 2 Diabetes MellitusUnited States
-
Bristol-Myers SquibbCompletedType 2 Diabetes MellitusSouth Africa, United States, Canada, Puerto Rico, Hungary, Germany, Czechia, Poland, Romania, United Kingdom
-
Charles University, Czech RepublicCompleted
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, Mexico, Argentina
-
Hadassah Medical OrganizationWithdrawn
-
Woman'sPfizer; American Cancer Society, Inc.; Our Lady of the Lake Regional Medical...WithdrawnInsulin Resistance | Breast Cancer Stage | Racial BiasUnited States
-
German Diabetes CenterYale UniversityEnrolling by invitationType2 DiabetesGermany
-
RenJi HospitalCompleted